Assesment of platelet antiaggregant activity of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees.




Lauraceae, platelet aggregation, arachidonic acid, adenosine diphosphate, epinephrine, collagen


Background: Some species of the Lauraceae family are known to produce secondary metabolites that have antiplatelet properties. Studies on the leaves of Nectandra amazonum Nees. have shown antiaggregant activity but the bark of this species has not been studied. Objectives: To assess the antiplatelet effect of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees. [N.V. “laurel amarillo”, Lauraceae] applying the “Born” turbidimetric method. Methods: The screening test compared the effects of a fraction of N. amazonum (0.1 mg/mL), acetylsalicylic acid (ASA, 0.5 mM, as reference standard) and dimethylsulphoxide (DMSO, 0.1%, as control) on human platelets stimulated with adenosine diphosphate (ADP, 2 µM), epinephrine (EPI, 1 uM (one micromolar)), collagen (COLL, 1 µg/mL) and arachidonic acid (AA, 0.2 mg/mL). Subsequently, the study focused on determining the antiaggregant potency of the N. amazonum fraction through concentration - response curves (from 1 µg/mL to 0.4 mg/mL), obtaining pIC50 (-log IC50) values against the platelet agonists. Results: Control platelets attained the highest percentage values of aggregation (96% AA, 89% EPI, 85% COLL, and 77% ADP). The N. amazonum fraction significantly reduced the aggregation effects (6% AA, 45% EPI, 10% COLL, 21% ADP), with values close to those obtained with ASA (17% AA, 21% EPI, 10% COLL, 20% ADP). According to concentration - response curves, the pIC50 values of the ethanolic fraction indicated the following order of potency: AA, 4.90 > ADP, 4.51 > COLL, 4.33 > EPI, 3.85. Conclusions: These results suggest that the N. amazonum Nees. ethanolic fraction elicited antiplatelet effects mainly related to the inhibition of the arachidonic acid pathway.

= 216 veces | PDF
= 128 veces|


Download data is not yet available.

Author Biographies

Jenaro Antonio ESPITIA CORREDOR, Universidad Nacional de Colombia.

Faculty of Sciences, Department of Pharmacy, MSc

Luis Enrique CUCA SUÁREZ, Universidad Nacional de Colombia.

Faculty of Sciences, Department of Chemistry, PhD

Mario Francisco GUERRERO PABÓN, Universidad Nacional de Colombia

Faculty of Sciences, Department of Pharmacy, PhD


WHO (2011). Global Atlas on Cardiovascular Disease Prevention and Control. Technical report, World Health Organization.

WHO (2014). Noncommunicable Diseases (NCD) Country Profiles, Colombia. Technical report, World Health Organization.

Verdier F, Fourcade L. Changes in cardiovascular risk factors in developing countries. Med Trop (Mars). 2007; 67(6):552-558.

Sudo M, Hirayama A. Treatment of anti-thrombotic therapy in coronary artery disease. Nihon Rinsho. 2014; 72(7):1276–1281.

Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol. 2012; 9(3):305-317.

Chen C, Yang FQ, Zhang Q, Wang FQ, Hu YJ, Xia ZN. (2015). Natural products for antithrombosis. Evid Based Complement Alternat Med. 2015; 876426, 17 p.

Ballabeni V, Tognolini M, Bertoni S, Bruni R, Guerrini A, Rueda GM, Barocelli E. Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador. Pharmacol Res. 2007; 55(1):23-30.

Ben Amor N, Bouaziz A, Romera-Castillo C, Salido S, LinaresPalomino PJ, Bartegi A, Salido GM, Rosado JA. Characterization of the intracellular mechanisms involved in the antiaggregant properties of cinnamtannin B-1 from bay wood in human platelets. J Med Chem. 2007; 50(16):3937-3944.

Dong HP, Wu HM, Chen SJ, Chen CY. The effect of butanolides from Cinnamomum tenuifolium on platelet aggregation. Molecules. 2013; 18(10):11836-11841.

Valdés-Barrera ID, Cuca-Suarez LE, Coy-Barrera ED. Nectandra amazonum-derived flavonoids as COX-1 inhibitors: in vitro and docking studies. Nat Prod Commun. 2014; 9(5):649-652.

Coy ED, Cuca LE, Sef kow M. COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans. Bioorg Med Chem Lett. 2009; 19(24):6922-6925.

Coy ED, Cuca LE. Three New 7.3,8.5-Connected Bicyclo[3.2.1]octanoids and Other Neolignans from Leaves of Nectandra amazonum Nees. (Lauraceae). Chem Pharm Bull. 2009; 57(6):639-642.

Vogel HG. (Ed). Drug Discovery and evaluation, Pharmacological assays, 2nd ed., Berlin Heidelberg New York: Springer Verlag; 2002. 280-282 p.

Noubiap JJ, Nansseu JR. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries? Vasc Health Risk Manag. 2015; 25(11):503-506.

Lalor N, Rodríguez L, Elissamburu P, Filipini E, Conde D, Nau G, Cura F, Trivi M. Clopidogrel versus prasugrel in acute coronary syndrome treated with coronary angioplasty. Medicina. 2015; 75(4):207-212




How to Cite

ESPITIA CORREDOR, J. A., CUCA SUÁREZ, L. E., & GUERRERO PABÓN, M. F. (2016). Assesment of platelet antiaggregant activity of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees. Vitae, 23(2), 119–123.



Natural Products

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> 

You may also start an advanced similarity search for this article.